| Home > Documents in Process > Prematurely Aged Human Microglia Exhibit Impaired Stress Response and Defective Nucleocytoplasmic Shuttling of ALS Associated FUS. > print |
| 001 | 282297 | ||
| 005 | 20251117095329.0 | ||
| 024 | 7 | _ | |a 10.1111/acel.70232 |2 doi |
| 024 | 7 | _ | |a pmid:40970514 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC12610945 |2 pmc |
| 024 | 7 | _ | |a 1474-9718 |2 ISSN |
| 024 | 7 | _ | |a 1474-9726 |2 ISSN |
| 024 | 7 | _ | |a 1474-9728 |2 ISSN |
| 037 | _ | _ | |a DZNE-2025-01267 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Hartmann, Christiane |0 0000-0001-8699-0794 |b 0 |
| 245 | _ | _ | |a Prematurely Aged Human Microglia Exhibit Impaired Stress Response and Defective Nucleocytoplasmic Shuttling of ALS Associated FUS. |
| 260 | _ | _ | |a Oxford [u.a.] |c 2025 |b Wiley-Blackwell |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1763369291_17166 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Microglia, the brain's resident immune cells, are crucial for maintaining healthy brain homeostasis. However, as the brain ages, microglia can shift from a neuroprotective to a neurotoxic phenotype, contributing to chronic inflammation and promoting neurodegenerative processes. Despite the importance of understanding microglial aging, there are currently few human in vitro models to study these processes. To address this gap, we have developed a model in which human microglia undergo accelerated aging through inducible progerin expression. HMC3-Progerin cells display key age-related markers such as activation of the senescence-associated secretory phenotype (SASP) as well as an increase in DNA damage. These prematurely aged HMC3 cells show a reduced response to LPS activation, exhibit impairments in essential microglial functions including decreased migration and phagocytosis as well as transcriptomic alterations including a shift observed in aging and neurodegeneration. Additionally, we observed an impaired stress response and a defect in nucleocytoplasmic transport, especially affecting the amyotrophic lateral sclerosis (ALS) associated protein FUS. This suggests that microglia play a contributory role in driving neurodegenerative processes in the aging brain. Our microglia aging model offers a valuable tool for exploring how aged microglia affect brain function, enhancing our understanding of their role in brain aging. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a FUS |2 Other |
| 650 | _ | 7 | |a aging |2 Other |
| 650 | _ | 7 | |a aging clock |2 Other |
| 650 | _ | 7 | |a amyotrophic lateral sclerosis |2 Other |
| 650 | _ | 7 | |a microglia |2 Other |
| 650 | _ | 7 | |a nucleocytoplasmic shuttling |2 Other |
| 650 | _ | 7 | |a progerin |2 Other |
| 650 | _ | 7 | |a senolytics |2 Other |
| 650 | _ | 7 | |a RNA-Binding Protein FUS |2 NLM Chemicals |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Microglia: metabolism |2 MeSH |
| 650 | _ | 2 | |a Microglia: pathology |2 MeSH |
| 650 | _ | 2 | |a Amyotrophic Lateral Sclerosis: metabolism |2 MeSH |
| 650 | _ | 2 | |a Amyotrophic Lateral Sclerosis: pathology |2 MeSH |
| 650 | _ | 2 | |a Amyotrophic Lateral Sclerosis: genetics |2 MeSH |
| 650 | _ | 2 | |a RNA-Binding Protein FUS: metabolism |2 MeSH |
| 650 | _ | 2 | |a Cellular Senescence |2 MeSH |
| 650 | _ | 2 | |a Active Transport, Cell Nucleus |2 MeSH |
| 650 | _ | 2 | |a Stress, Physiological |2 MeSH |
| 650 | _ | 2 | |a Phagocytosis |2 MeSH |
| 700 | 1 | _ | |a Haß, Christina |b 1 |
| 700 | 1 | _ | |a Knobloch, Muriel |b 2 |
| 700 | 1 | _ | |a Barrantes, Israel |b 3 |
| 700 | 1 | _ | |a Fumagalli, Laura |0 0000-0002-9333-926X |b 4 |
| 700 | 1 | _ | |a Premereur, Jessie |b 5 |
| 700 | 1 | _ | |a Markert, Franz |0 0000-0001-6502-2567 |b 6 |
| 700 | 1 | _ | |a Peters, Maite |b 7 |
| 700 | 1 | _ | |a Koromila, Georgia |b 8 |
| 700 | 1 | _ | |a Hartmann, Alexander |b 9 |
| 700 | 1 | _ | |a Jäger, Kathrin |b 10 |
| 700 | 1 | _ | |a Abel, Jette |b 11 |
| 700 | 1 | _ | |a Mancuso, Renzo |b 12 |
| 700 | 1 | _ | |a Storch, Alexander |0 P:(DE-2719)9000306 |b 13 |
| 700 | 1 | _ | |a Walter, Michael |b 14 |
| 700 | 1 | _ | |a Fuellen, Georg |b 15 |
| 700 | 1 | _ | |a Hermann, Andreas |0 P:(DE-2719)2811732 |b 16 |e Last author |u dzne |
| 773 | _ | _ | |a 10.1111/acel.70232 |g Vol. 24, no. 11, p. e70232 |0 PERI:(DE-600)2099130-7 |n 11 |p e70232 |t Aging cell |v 24 |y 2025 |x 1474-9718 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/282297/files/DZNE-2025-01267.pdf |y Restricted |
| 856 | 4 | _ | |u https://pub.dzne.de/record/282297/files/DZNE-2025-01267.pdf?subformat=pdfa |x pdfa |y Restricted |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)9000306 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 16 |6 P:(DE-2719)2811732 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2024-12-17 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b AGING CELL : 2022 |d 2024-12-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2024-08-08T17:04:24Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2024-08-08T17:04:24Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Peer review |d 2024-08-08T17:04:24Z |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2024-08-08T17:04:24Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2024-12-17 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2024-12-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-17 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-17 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b AGING CELL : 2022 |d 2024-12-17 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2024-12-17 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2024-12-17 |
| 920 | 1 | _ | |0 I:(DE-2719)1511100 |k AG Hermann |l Translational Neurodegeneration |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)5000014 |k AG Storch |l Non-Motor Symptoms in Parkinson's disease |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a EDITORS |
| 980 | _ | _ | |a VDBINPRINT |
| 980 | _ | _ | |a I:(DE-2719)1511100 |
| 980 | _ | _ | |a I:(DE-2719)5000014 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|